However, further investigation may be required to understand whether RasGRP1-mediated EGFR-SOS1-Ras-ERK or EGFR-SOS1-Ras-AKT signalling inhibition is a general mechanism that affects other inflammation-associated cancers. Here, AKT1 is linked to cancer.